tiprankstipranks
Trending News
More News >
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
US Market

ABVC BioPharma (ABVC) Price & Analysis

Compare
108 Followers

ABVC Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.73%0.07%98.54%
Insiders
0.07% Other Institutional Investors
98.54% Public Companies and
Individual Investors

ABVC FAQ

What was ABVC BioPharma, Inc.’s price range in the past 12 months?
ABVC BioPharma, Inc. lowest stock price was $0.40 and its highest was $4.00 in the past 12 months.
    What is ABVC BioPharma, Inc.’s market cap?
    ABVC BioPharma, Inc.’s market cap is $67.76M.
      When is ABVC BioPharma, Inc.’s upcoming earnings report date?
      ABVC BioPharma, Inc.’s upcoming earnings report date is Nov 17, 2025 which is in 131 days.
        How were ABVC BioPharma, Inc.’s earnings last quarter?
        ABVC BioPharma, Inc. released its earnings results on Mar 28, 2025. The company reported $0.016 earnings per share for the quarter, beating the consensus estimate of N/A by $0.016.
          Is ABVC BioPharma, Inc. overvalued?
          According to Wall Street analysts ABVC BioPharma, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does ABVC BioPharma, Inc. pay dividends?
            ABVC BioPharma, Inc. does not currently pay dividends.
            What is ABVC BioPharma, Inc.’s EPS estimate?
            ABVC BioPharma, Inc.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does ABVC BioPharma, Inc. have?
            ABVC BioPharma, Inc. has 16,981,592 shares outstanding.
              What happened to ABVC BioPharma, Inc.’s price movement after its last earnings report?
              ABVC BioPharma, Inc. reported an EPS of $0.016 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.5%.
                Which hedge fund is a major shareholder of ABVC BioPharma, Inc.?
                Currently, no hedge funds are holding shares in ABVC

                ABVC BioPharma Stock Smart Score

                7
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                439.18%
                12-Months-Change

                Fundamentals

                Return on Equity
                -27.00%
                Trailing 12-Months
                Asset Growth
                1.29%
                Trailing 12-Months

                Company Description

                ABVC BioPharma, Inc.

                ABVC BioPharma, Inc. (ABVC) is a biopharmaceutical company engaged in the development of new drugs and medical devices. The company operates within the pharmaceutical and biotechnology sectors, focusing on innovative therapeutics for the treatment of central nervous system disorders, oncology, and other unmet medical needs. ABVC's core products include a portfolio of drug candidates and medical device technologies that are in various stages of clinical development.
                Similar Stocks
                Company
                Price & Change
                Follow
                Cocrystal Pharma
                BiomX
                Bolt Biotherapeutics
                SAB Biotherapeutics
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis